StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.96+0.00 (0.00%)

Close on Nov 13, 2026Market cap $59.76MP/E –Yield –

XBiotech cash

Cash and short-term investments held at the end of each period.

XBiotech's cash was $105.04M at Sep 30, 2026. For fiscal 2025 it was $125.55M, down 27.3% from the year before. Over ten years it grew 3.3% a year on average. The highest annual figure on record is $714.59M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$125.55M-27.3%
FY2024Dec 31, 2024$172.68M-13.7%
FY2023Dec 31, 2023$200.02M-8.0%
FY2022Dec 31, 2022$217.48M-8.2%
FY2021Dec 31, 2021$236.98M-0.2%
FY2020Dec 31, 2020$237.37M-66.8%
FY2019Dec 31, 2019$714.59M+4416.2%
FY2018Dec 31, 2018$15.82M-50.2%
FY2017Dec 31, 2017$31.77M-7.4%
FY2016Dec 31, 2016$34.32M-62.3%
FY2015Dec 31, 2015$91.05M+58.8%
FY2014Dec 31, 2014$57.33M+691.4%
FY2013Dec 31, 2013$7.24M+73.8%
FY2012Dec 31, 2012$4.17M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$105.04M-28.7%
Q2 FY2026Jun 30, 2026$109.53M-28.4%
Q1 FY2026Mar 31, 2026$115.46M-25.9%
Q4 FY2025Dec 31, 2025$125.55M-27.3%
Q3 FY2025Sep 30, 2025$147.37M-19.5%
Q2 FY2025Jun 30, 2025$152.94M-18.9%
Q1 FY2025Mar 31, 2025$155.90M-22.5%
Q4 FY2024Dec 31, 2024$172.68M-13.7%
Q3 FY2024Sep 30, 2024$183.12M-9.4%
Q2 FY2024Jun 30, 2024$188.53M-7.9%
Q1 FY2024Mar 31, 2024$201.04M-5.5%
Q4 FY2023Dec 31, 2023$200.02M-8.0%
Q3 FY2023Sep 30, 2023$202.19M-8.1%
Q2 FY2023Jun 30, 2023$204.77M-9.3%
Q1 FY2023Mar 31, 2023$212.66M-8.3%
Q4 FY2022Dec 31, 2022$217.48M-8.2%
Q3 FY2022Sep 30, 2022$220.10M-7.9%
Q2 FY2022Jun 30, 2022$225.79M-28.4%
Q1 FY2022Mar 31, 2022$231.82M-3.4%
Q4 FY2021Dec 31, 2021$236.98M-0.2%
Q3 FY2021Sep 30, 2021$238.88M+0.2%
Q2 FY2021Jun 30, 2021$315.26M+37.2%
Q1 FY2021Mar 31, 2021$239.88M-0.7%
Q4 FY2020Dec 31, 2020$237.37M-66.8%
Q3 FY2020Sep 30, 2020$238.43M+491.1%
Q2 FY2020Jun 30, 2020$229.70M+411.3%
Q1 FY2020Mar 31, 2020$241.54M+1909.7%
Q4 FY2019Dec 31, 2019$714.59M+4416.2%
Q3 FY2019Sep 30, 2019$40.34M+93.5%
Q2 FY2019Jun 30, 2019$44.92M+80.8%
Q1 FY2019Mar 31, 2019$12.02M-57.7%
Q4 FY2018Dec 31, 2018$15.82M-50.2%
Q3 FY2018Sep 30, 2018$20.85M-46.5%
Q2 FY2018Jun 30, 2018$24.85M-45.9%
Q1 FY2018Mar 31, 2018$28.42M-48.0%
Q4 FY2017Dec 31, 2017$31.77M-7.4%
Q3 FY2017Sep 30, 2017$38.98M–
Q2 FY2017Jun 30, 2017$45.95M–
Q1 FY2017Mar 31, 2017$54.63M–
Q4 FY2016Dec 31, 2016$34.32M–

More XBiotech figures

See a number that looks wrong?